Medications for Macular Degeneration
11 results
Ahzantive (aflibercept-mrbb)
(aflibercept-mrbb)Valorum Biologics Inc
Usage: AHZANTIVE is indicated for the treatment of neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, and diabetic retinopathy.
Beovu (brolucizumab)
(brolucizumab)Novartis Pharmaceuticals Corporation
Usage: BEOVU® is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD) and diabetic macular edema (DME).
Byooviz (ranibizumab-nuna)
(ranibizumab-nuna)BIOGEN INC.
Usage: BYOOVIZ is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV).
Cimerli (ranibizumab-eqrn)
(ranibizumab-eqrn)Coherus BioSciences Inc
Usage: CIMERLI is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME), diabetic retinopathy (DR), and myopic choroidal neovascularization (mCNV).
Encelto (revakinagene taroretcel-lwey)
(revakinagene taroretcel-lwey)Neurotech Pharmaceuticals, Inc.
Usage: ENCELTO is indicated for the treatment of adults with idiopathic macular telangiectasia type 2 (MacTel).
Eylea hd (aflibercept)
(aflibercept)Regeneron Pharmaceuticals, Inc
Usage: EYLEA HD is indicated for treating neovascular (wet) age-related macular degeneration (nAMD), diabetic macular edema (DME), and diabetic retinopathy (DR).
Lucentis (ranibizumab)
(RANIBIZUMAB)Genentech, Inc.
Usage: LUCENTIS is indicated for treating neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME), diabetic retinopathy (DR), and myopic choroidal neovascularization (mCNV).
Macular degeneration (elaps corallinus, aconitum nap.,aur. met., baryta carb., belladonna, crotalus horridus, gelsemium, hamamelis, lachesis, merc. viv.,phosphorus, picricum ac., plumbum met., pulsatilla,rhus toxicodendron, stramonium, theridion, euphrasia)
(Elaps corallinus, Aconitum nap.,Aur. met., Baryta carb., Belladonna, Crotalus horridus, Gelsemium, Hamamelis, Lachesis, Merc. viv.,Phosphorus, Picricum ac., Plumbum met., Pulsatilla,Rhus toxicodendron, Stramonium, Theridion, Euphrasia)Newton Laboratories, Inc.
Usage: This drug is indicated for the treatment of symptoms associated with atrophic and neovascular forms of macular degeneration, as well as issues related to the macula and retina.
Macular degeneration (elaps corallinus, aconitum nap.,aur. met., baryta carb., belladonna, crotalus horridus, gelsemium, hamamelis, lachesis, merc. viv.,phosphorus, picricum ac., plumbum met., pulsatilla,rhus toxicodendron, stramonium, theridion, euphrasia)
(Elaps corallinus, Aconitum nap.,Aur. met., Baryta carb., Belladonna, Crotalus horridus, Gelsemium, Hamamelis, Lachesis, Merc. viv.,Phosphorus, Picricum ac., Plumbum met., Pulsatilla,Rhus toxicodendron, Stramonium, Theridion, Euphrasia)Newton Laboratories, Inc.
Usage: The drug is indicated for symptoms of atrophic and neovascular macular degeneration, along with associated symptoms affecting the macula and retina.
Susvimo (ranibizumab)
(Ranibizumab)Genentech, Inc.
Usage: SUSVIMO (ranibizumab injection) is indicated for treating Neovascular (wet) Age-related Macular Degeneration (AMD) and Diabetic Macular Edema (DME) in patients who have previously responded to at least two intravitreal injections of a Vascular Endothelial Growth Factor (VEGF) inhibitor.